{"filings":[{"id":1066480,"accession_number":"0001493152-26-028822","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-06-16T12:30:21+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Canton Strategic Holdings authorizes $50M share repurchase program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved up to $50M in common stock repurchases on June 11, 2026; press release June 16.","Shares may be bought on open market or privately; Rule 10b-18 plan with Virtu Americas LLC as agent.","Commission of $0.02 per share paid to broker; plan continues until terminated by either party.","CEO Mark Wendland cited confidence in platform and commitment to returning capital to shareholders.","Repurchases subject to market conditions, capital availability; program modifiable or suspendable at any time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110202,"accession_number":"0001493152-26-013823","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Canton Strategic Holdings reports FY2025 net loss of $35.9M, holds $501.8M in Canton Coin","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $35.9M ($1.12 per diluted share); accumulated deficit $72.8M; no revenue recognized.","Held 3.34B CC at fair value $501.8M; $17M cash; recorded $22M unrealized loss on digital assets.","Operating expenses rose to $20.1M from $12.4M, driven by digital asset transition and $6M non-recurring comp.","Milestones: $545M private placement (Nov 2025), Super Validator approval, $55M offering in early 2026.","Appointed Mark Wendland CEO/Chairman; added ex-CFTC commissioner Jill Sommers and William Wiley to board."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110201,"accession_number":"0001493152-26-008716","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Canton Strategic Holdings enters $300M ATM sales agreement with Clear Street and Virtu","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aggregate gross sales price of $300,000,000 available for issuance under amended and restated sales agreement.","Virtu Americas LLC added as a sales agent; President Street LLC terminated as agent as of Dec 3, 2025.","Sales agents receive commission of up to 3.00% of aggregate gross proceeds from common stock sales.","Shares offered at the market under existing S-3 registration statement filed Jan 9, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110200,"accession_number":"0001493152-26-008651","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Canton Strategic Holdings CEO Mark Wendland elected to Canton Foundation Board","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Mark Wendland, Chairman and CEO, elected to Canton Foundation Board of Directors.","Canton Strategic Holdings becomes a Premier Member of the Foundation.","Foundation governs Canton Network, including Global Synchronizer and validator framework.","Existing board includes senior leaders from DTCC, Euroclear, HSBC, and other global institutions.","Appointment aligns with accelerating institutional adoption of Canton Network."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110199,"accession_number":"0001493152-26-007277","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-02-18T23:59:59+00:00","items":["5.03","7.01","9.01"],"status":"ready","headline":"Tharimmune rebrands to Canton Strategic Holdings, ticker changes to CNTN; unveils digital asset treasury strategy","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Corporate name changed to Canton Strategic Holdings, Inc.; new NASDAQ ticker CNTN effective Feb. 18, 2026.","Company executes digital asset treasury strategy including Canton Coin acquisition and operation of a Super Validator.","Previously closed $545M private placement in Nov. 2025; recent $55M registered offering completed for growth capital.","Board appointments include former CFTC Commissioner Jill Sommers and DRW's William Wiley to deepen institutional expertise.","Company remains first publicly traded firm supported by Canton Foundation, also retains clinical-stage biotech R&D."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110208,"accession_number":"0001493152-26-005453","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-02-06T23:59:59+00:00","items":["5.02","7.01","8.01","9.01"],"status":"ready","headline":"Tharimmune appoints Angela Radkowski as COO and CEO Mark Wendland as Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Angela Radkowski appointed COO effective Feb 5, 2026; previously Operations Strategy Lead at DRW and Citadel.","CEO Mark Wendland elected Chairman of the Board; Vincent LoPriore steps down as Chairman but remains director.","COO Radkowski receives $300k base salary, $100k target annual bonus, and 12 months severance on qualifying termination.","Company regained Nasdaq compliance with board independence rule after electing two independent directors on Jan 30, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110207,"accession_number":"0001493152-26-004650","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Tharimmune shareholders approve board election, share issuances and 7M share plan increase","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shareholders elected Jill Sommers and William Wiley to the board with strong vote majorities (Sommers 19.95M for, Wiley 20.05M for).","Approved issuance of shares underlying Strategic Advisor Warrants (19.95M for), Cryptocurrency Pre-Funded Warrants (19.95M for), and Advisor RSUs (19.98M for).","Approved amendment to 2023 Omnibus Equity Incentive Plan increasing available shares by 7M (19.07M for).","Press release highlights new directors' backgrounds: Sommers former CFTC Commissioner, Wiley DRW Chief of Staff, to guide Canton Network strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110206,"accession_number":"0001493152-26-003539","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-01-26T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Tharimmune approves expanded role as Super Validator on Canton Network","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Tharimmune (NASDAQ: THAR) approved to operate a Super Validator on the Canton Network.","Super Validators process over 700,000 daily transactions totaling $9 trillion in monthly volume.","Company will provide quarterly research on onchain analytics, governance, tokenomics and host webinars.","Tharimmune is the first publicly traded company to leverage Canton Coin (CC) for digital asset treasury.","CEO Mark Wendland highlighted the network's role in transforming global financial infrastructure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110205,"accession_number":"0001493152-26-003242","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-01-22T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Tharimmune closes $55M registered direct offering of 1.8M shares and pre-funded warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$55M from 1,800,000 shares at $2.92 and pre-funded warrants for 17M shares at $2.9199.","Proceeds for expansion of Canton-centric digital asset treasury strategy and general working capital.","ATM program raised $7.1M through January 16, 2026.","Offering closed January 22, 2026; Clear Street acted as sole underwriter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110204,"accession_number":"0001493152-26-002787","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Tharimmune prices $55M offering: 1.8M shares at $2.92, 17M pre-funded warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering totals $55M; includes 1,800,000 shares at $2.92 per share.","Pre-funded warrants to purchase up to 17,000,000 shares at $2.9199 each.","Expected close on or about Jan 21, 2026; proceeds for treasury strategy and working capital.","Clear Street acting as sole bookrunner; offering under shelf registration filed Jan 9, 2026.","Tharimmune is first public company leveraging Canton Coin to digitize traditional financial markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110203,"accession_number":"0001493152-26-002421","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2026-01-15T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Tharimmune receives Nasdaq noncompliance notice for board independence; plans cure at Jan 30 meeting","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Tharimmune on Jan 9, 2026 of noncompliance with Listing Rule 5605 (majority independent directors) following resignations of Nancy Davis and Sanam Parikh effective Nov 6, 2025.","Cure period ends on earlier of next annual shareholders' meeting or Nov 6, 2026; if annual meeting before May 5, 2026, then May 5, 2026.","Company will seek shareholder approval at a special meeting on Jan 30, 2026 to elect two additional independent directors to the Board.","After the special meeting, the Company expects a majority of its Board to be independent, regaining compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126765,"accession_number":"0001493152-25-027373","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-12-12T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Tharimmune appoints Jacob Asbury as CFO, replaces interim CFO Sireesh Appajosyula","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jacob Asbury appointed CFO effective December 10, 2025; base salary $300,000/year plus annual target bonus of $100,000.","Asbury previously CFO of Clear Street Group (Sept 2021-Dec 2023) and Instinet Incorporated (2010-2020).","Outgoing interim CFO Sireesh Appajosyula remains CEO of subsidiary Gravitas Life Sciences; no change to his employment terms.","Press release highlights Tharimmune's digital asset treasury strategy using Canton Coin and Super Validator application.","Tharimmune is the first publicly traded company supported by the Canton Foundation to advance institutional blockchain adoption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126764,"accession_number":"0001493152-25-021577","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tharimmune Appoints Sireesh Appajosyula as Interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["On November 7, 2025, Tharimmune's Board appointed Sireesh Appajosyula as interim Chief Financial Officer.","The interim term is not to extend beyond December 31, 2025.","Mr. Appajosyula's previously disclosed employment agreement with the Company remains in effect."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126763,"accession_number":"0001493152-25-021152","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Tharimmune closes $545M private placement, appoints new CEO and President, pivots to Canton Network blockchain strategy","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed $545M private placement at $3.075/share with DRW, Liberty City Ventures, others; proceeds to acquire Canton Coin and support Canton Network.","Appointed Mark Wendland (ex-DRW Partner) as CEO and Mark Toomey (ex-Liberty City Ventures) as President; Wendland joins board.","Company to operate as Super Validator on Canton Network, a privacy-enabled blockchain with trillions in assets on chain.","Also entered into ATM sales agreement for up to $64.9M of common stock with Clear Street and President Street Global.","Company retains clinical-stage biotech operations but primarily focuses new digital asset treasury strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126762,"accession_number":"0001493152-25-021101","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Tharimmune raises $545M in PIPE, appoints new CEO, pivots to crypto treasury","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 25,966,048 shares and 151,456,115 pre-funded warrants at $3.075/share, raising ~$545M gross.","Proceeds to establish 'Canton Coin treasury' and fund operations; use signals crypto strategy shift.","Directors Nancy Davis and Sanam Parikh resigned Nov 6, 2025; former CEO Sireesh Appajosyula moves to subsidiary CEO.","Mark Wendland (ex-DRW Holdings) appointed CEO and director; Mark Toomey (ex-Liberty City Ventures) appointed President.","New CEO receives $500K base salary, $150K sign-on bonus, and 1.0% fully diluted RSU grant; President gets similar terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126761,"accession_number":"0001493152-25-020824","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tharimmune launches private placement of stock and pre-funded warrants at $3.075 per share","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Offering includes shares of common stock and pre-funded warrants for both cash and cryptocurrency consideration.","Pre-funded warrants priced at $3.075 less $0.0001 per warrant; lock-up until resale registration effective.","Strategic advisor warrants issued equal to 5% of fully diluted shares at $0.001 exercise price.","Aggregate offering size not disclosed; investor presentation furnished confidentially as Exhibit 99.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126760,"accession_number":"0001493152-25-020553","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Tharimmune raises ~$540M in private placement for Canton Coin treasury; appoints Wendland CEO of DAT","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$540M from sale of common stock/pre-funded warrants at $3.075/share; closing expected Nov 6, 2025.","Lead investors DRW and Liberty City Ventures; 20+ participants include ARK Invest, Kraken, Polychain Capital.","Proceeds to acquire Canton Coin (CC) and operate as Super Validator on the Canton Network.","Mark Wendland appointed CEO of digital asset treasury strategy; Mark Toomey appointed President.","Shareholder approval required for crypto pre-funded warrants; failure by May 13, 2026 triggers return of CC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126759,"accession_number":"0001493152-25-017766","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-10-10T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Tharimmune increases authorized common stock from 250M to 1B shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed Certificate of Amendment with Delaware Secretary of State on October 10, 2025.","Authorized common stock raised from 250,000,000 to 1,000,000,000 shares.","Company states the amendment also effectuates a reverse stock split (no further details provided)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126758,"accession_number":"0001493152-25-017596","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-10-09T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Tharimmune stockholders approve 4x authorized share increase and expanded equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized common shares may increase from 250M to 500M–1B; board has discretion until Oct 9, 2026.","Equity plan reserved shares raised from 792,602 to 2,000,000; proposal passed 2,419,032 for, 86,170 against.","Stockholders approved future non-public offerings under Nasdaq Rule 5635 without further stockholder approval.","All three proposals passed at special meeting on Oct 9, 2025 with 3,907,536 shares represented (quorum).","Authorized share increase vote: 3,764,397 for, 129,427 against, 13,711 abstain (no broker non-votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126757,"accession_number":"0001493152-25-017018","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Tharimmune amends warrants for 3.4M shares to be immediately exercisable","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered warrant amendment with holders of warrants covering 3,408,110 common shares.","Warrants amended to become immediately exercisable as of October 1, 2025.","No other terms of the warrants were modified according to the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143549,"accession_number":"0001493152-25-012808","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-09-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tharimmune increases CEO and Chairman base salary to $385,000, triples change-of-control severance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Sireesh Appajosyula and Executive Chairman Vincent LoPriore base salary increased by $100,000 to $385,000.","Change-of-control severance multiplier increased from 2x to 3x base salary plus target bonus for both.","Changes approved by Compensation Committee on September 2, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143548,"accession_number":"0001641172-25-026666","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-09-05T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Tharimmune regains Nasdaq compliance with $6.9M equity as of Aug 31, 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq letter dated Sept 5, 2025 confirms stockholders' equity of $6,876,335.","Company complies with Listing Rule 5550(b)(1); deficiency cured.","Nasdaq compliance matter is now closed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143547,"accession_number":"0001641172-25-026620","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-09-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Tharimmune regains Nasdaq equity compliance after raises totaling $7.05M","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq deficiency notice Apr 1, 2025 for stockholders' equity below $2.5M minimum.","Raised ~$1.7M in registered direct offering on Jul 25, 2025 and ~$5.35M on Aug 27, 2025.","As of Aug 31, 2025, stockholders' equity is $6.88M, exceeding Nasdaq's $2.5M requirement.","Cash and cash equivalents stood at $8.78M as of Aug 31, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143546,"accession_number":"0001641172-25-025476","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-08-26T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Tharimmune raises $5.35M in registered direct offering at $4.50/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 1,188,888 shares or common stock equivalents at $4.50 per share.","Expected closing date August 27, 2025, subject to customary conditions.","Placement agents President Street Global and RF Lafferty receive 10% cash fee.","Shelf registration statement (Form S-3) previously effective on March 24, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143542,"accession_number":"0001641172-25-025585","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K/A","filed_at":"2025-08-26T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Tharimmune enters securities purchase agreement for $5.35 million registered direct offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering consists of 1,188,888 shares of common stock (or common stock equivalents) at $4.50 per share.","Placement agents President Street Global and RF Lafferty will receive 10% cash fee on gross proceeds.","Closing expected August 27, 2025, subject to customary conditions.","Pre-Funded Warrants with $0.001 exercise price available in lieu of shares to avoid beneficial ownership limit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143545,"accession_number":"0001641172-25-022615","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Tharimmune appoints Nancy Davis to board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Nancy Davis, founder of Race to Erase MS and Cure Addiction Now, joins Tharimmune board effective August 4, 2025.","Davis brings patient advocacy expertise and has raised over $56M for MS research through her foundation.","Her appointment aligns with Tharimmune's focus on TH104 for opioid countermeasures and broader pipeline.","Davis will serve until the 2026 annual meeting, with compensation consistent with other non-employee directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143544,"accession_number":"0001641172-25-021772","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Tharimmune raises $1.225M in private placement of common stock and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $1,225,003 from sale of 641,190 common shares, 103,490 pre-funded warrants, and 744,680 common warrants.","Per-unit price: $1.645 for one share (or pre-funded warrant) plus one common warrant; common warrants exercisable at $1.52/share for 7 years.","Pre-funded warrants exercisable immediately at $0.001/share; common warrants exercisable after 6 months with 4.99%/9.99% ownership cap.","Net proceeds to be used for clinical development and working capital; President Street Global acted as placement agent.","Closing occurred July 31, 2025; securities issued in reliance on Section 4(a)(2) and Rule 506."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143543,"accession_number":"0001641172-25-021118","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Tharimmune prices $1.74M unit offering of common stock and warrants at $1.786/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering: 414,331 shares, 559,910 pre-funded warrants, and 974,241 common warrants (exercise $1.66).","Gross proceeds ~$1.74M before fees; net proceeds for working capital and general corporate purposes.","Placement agent President Street Global receives 7% cash fee on gross proceeds and warrant exercises.","Closing expected July 25, 2025; registered under effective S-3 shelf; common warrants unregistered.","Dilution: total shares plus warrant shares equal ~1.95M common shares if all exercised."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161744,"accession_number":"0001641172-25-016291","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Kelly Anderson resigns from Tharimmune Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kelly Anderson resigned from the Board effective June 22, 2025 for personal reasons.","No replacement director has been announced; resignation is immediate.","Mr. Anderson's departure reduces Board size; company has not disclosed any succession plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161743,"accession_number":"0001641172-25-015675","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Tharimmune raises ~$2.5M in private placement of equity and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$2.5M from 1,551,351 shares, pre-funded warrants for 137,838 shares at $0.001.","Series A warrants for 1,689,189 shares at $1.29; Series B for 844,572 shares at $3.00.","Warrants exercisable after 6 months, term of 5.5 years from issuance date.","Proceeds to fund clinical development and working capital; closing expected June 20, 2025.","President Street Global acted as exclusive placement agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161742,"accession_number":"0001641172-25-015248","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tharimmune CFO Don Kim resigns effective June 10, 2025; no replacement named","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Don Kim resigned for personal reasons, effective immediately on June 10, 2025.","No successor has been appointed or disclosed as of the filing date.","CEO Sireesh Appajosyula signed the 8-K; no interim CFO announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161741,"accession_number":"0001641172-25-014753","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-06-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tharimmune CEO resigns; appoints Sireesh Appajosyula as new CEO, adds director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Randy Milby resigned for personal reasons; receives $133,500 settlement and accelerated vesting of unvested options, contingent on $3M+ financing.","Sireesh Appajosyula appointed CEO; employment agreement provides $285K base salary, 60% bonus target, 5-year term, severance benefits.","Vincent LoPriore, previously named Executive Chairman, entered employment agreement with same $285K base, bonus, and severance terms.","James Gordon Liddy appointed to the Board effective June 11, 2025.","Milby's unvested stock options vested immediately upon resignation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161740,"accession_number":"0001641172-25-014534","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tharimmune shareholders elect directors, ratify auditor, approve equity plan at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected; Randy Milby received 480,332 for, 296,465 abstain, 352,661 broker non-votes.","Ratification of Rosenberg Rich Baker Berman as auditor approved with 1,085,531 for (~96% of votes cast).","Amended equity incentive plan approved with 435,460 for, 339,548 against, 1,789 abstain, 352,661 broker non-votes (56% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161739,"accession_number":"0001641172-25-009480","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-05-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tharimmune appoints Vincent LoPriore as Executive Chairman, replacing Randy Milby","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Vincent LoPriore, a current director, named Executive Chairman effective May 9, 2025.","Randy Milby stepped down as Chairman but remains CEO of Tharimmune.","Change is effective immediately; no other board or officer changes disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161738,"accession_number":"0001641172-25-006499","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-04-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tharimmune appoints Clay Kahler and Gary Stetz to Board, expanding to 9 members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased from 8 to 9 on April 28, 2025.","Clay Kahler appointed as member of the Board.","Gary Stetz appointed as member of the Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161737,"accession_number":"0001641172-25-006101","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Two directors retire from Tharimmune board; not seeking re-election at June 10 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leonard Mazur and Lynne Bui, MD will retire from the Board effective June 10, 2025.","They will not stand for re-election at the 2025 Annual Meeting of Stockholders.","Retirements are not related to any disagreements with the Company, management, or Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161736,"accession_number":"0001641172-25-003617","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-04-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tharimmune appoints Vincent LoPriore to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased to seven members on April 9, 2025.","Vincent LoPriore appointed as new board member effective April 9, 2025.","Tharimmune (NASDAQ: THAR) is a clinical-stage biopharmaceutical company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161735,"accession_number":"0001641172-25-002817","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-04-04T23:59:59+00:00","items":[],"status":"ready","headline":"Tharimmune receives Nasdaq delisting notice for insufficient stockholders' equity","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Tharimmune on April 1, 2025, that stockholders' equity of $1,307,642 falls below the $2,500,000 minimum required by Listing Rule 5550(b)(1).","Company has 45 days (until ~May 16) to submit a plan to regain compliance; if accepted, up to 180 days from April 1 to comply.","No immediate impact on listing; trading continues on Nasdaq Capital Market pending compliance process."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179833,"accession_number":"0001493152-25-008538","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Tharimmune announces CFO transition: Hess to depart March 26, Kim effective March 27","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Thomas Hess resigned effective March 26, 2025; no disagreement with company operations or policies.","Don Kim appointed CFO effective March 27, 2025; consulting agreement at $225/hour for 12-month term.","Kim previously served as CFO of UroGen Pharma (2022-2024) and held finance roles at Strides Pharma, Sun Pharma, and Zoetis.","Kim is a licensed CPA and will serve as an independent contractor, not an employee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196602,"accession_number":"0001493152-24-049148","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-12-06T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Tharimmune raises $2.02M in private placement for TH104 development","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$2.02M from issuance of 961,446 common shares (or equivalents) and warrants for 480,723 shares at $2.10 per unit.","Warrants exercisable at $2.031/share, starting 6 months after issuance, expiring in 5.5 years.","Placement led by Gravitas Capital and SDS Capital Group; President Street Global as exclusive agent.","Net proceeds to fund clinical development of TH104 (pruritus in PBC) and working capital.","Closing expected on or about December 9, 2024, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196601,"accession_number":"0001493152-24-047175","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-11-21T23:59:59+00:00","items":["5.02","8.01"],"status":"ready","headline":"Tharimmune appoints board member, terminates Intract Pharma merger LOI","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board increased to six members; Sanam Parikh appointed as director effective November 20, 2024.","Terminated non-binding exclusive Letter of Intent with Intract Pharma Ltd., dated August 19, 2024, effective immediately.","No further details provided on termination reasons or future plans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212907,"accession_number":"0001493152-24-038730","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-09-30T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tharimmune signs nonbinding LOI to merge with Intract Pharma; 49% stake for Intract shareholders","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Tharimmune and Intract Pharma entered nonbinding LOI; Tharimmune to acquire Intract for restricted stock.","Intract shareholders will own 49% of combined entity; merger expected to close in Q1 2025.","Combined company will leverage Intract's Soteria and Phloral oral delivery platforms for biologics.","Existing license for oral anti-TNF antibody (INT-023/TH023) from Intract remains unaffected.","Transaction aims to expand Tharimmune's pipeline in inflammation and immunology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212906,"accession_number":"0001493152-24-036310","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-09-16T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Tharimmune licenses oral infliximab from Intract Pharma for global development","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Exclusive global license (ex-South Korea) to INT-023/TH023, an oral anti-TNF-α monoclonal antibody infliximab.","Intract received upfront payment, eligible for equity-linked payments, milestones, and mid-single-digit royalties on net sales.","Tharimmune holds right of first refusal to continue development after Phase 2 trial.","Option to license Intract's Soteria/Phloral platform for up to four additional targets.","Oral formulation aims to replace IV infliximab (Remicade) for autoimmune diseases; multibillion-dollar market opportunity cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231984,"accession_number":"0001493152-24-024516","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-06-20T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Tharimmune announces $2.08M private placement; 659K shares & warrants at $3.16/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$2.08M from sale of 659,545 shares (or equivalents) and warrants to purchase 329,771 shares.","Warrants exercisable at $3.09 per share beginning 6 months after issuance, expiring 5.5 years later.","Closing expected June 21, 2024; led by SDS Capital Group and Gravitas Capital.","Net proceeds to fund clinical development and working capital, including TH104 program."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231983,"accession_number":"0001493152-24-023474","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-06-11T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Tharimmune regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Received Nasdaq notice on June 11, 2024, confirming compliance with Listing Rule 5550(a)(2).","Previously disclosed non-compliance on June 12, 2023; now resolved.","Company's common stock (THAR) continues listing on Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231982,"accession_number":"0001493152-24-023193","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-06-07T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Tharimmune enters $0.0001 par value common stock ATM facility with Rodman & Renshaw","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ATM Agreement allows Tharimmune to sell shares of common stock from time to time through Rodman & Renshaw as sales agent.","Sales will be made by methods deemed \"at the market\" under Rule 415(a)(4), including direct sales on Nasdaq.","Manager receives 3.0% commission on gross proceeds; no obligation for Tharimmune to sell any shares.","Shares offered under effective shelf registration statement (333-270684) and prospectus supplement dated June 7, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231981,"accession_number":"0001493152-24-021014","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-05-22T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Tharimmune announces 1-for-15 reverse stock split to meet Nasdaq $1 minimum bid","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["1-for-15 reverse split effective after market close on May 24, 2024; post-split trading begins May 28, 2024.","Post-split shares outstanding approximately 785,978; fractional shares rounded up to whole shares.","Reverse split intended to regain compliance with Nasdaq's $1.00 per share minimum bid requirement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231980,"accession_number":"0001493152-24-019272","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-05-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tharimmune shareholders approve reverse stock split (1:2 to 1:50) and equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 5 director nominees elected with vote totals ranging from 2,848,203 to 2,871,156 for.","Ratification of auditor Rosenberg Rich Baker Berman P.A. passed: 4,800,694 for, 123,028 against.","Reverse stock split authorized (range 1:2 to 1:50) to be completed by May 14, 2025; 4,246,167 for, 673,553 against.","Amended 2023 Omnibus Equity Incentive Plan approved: 2,405,905 for, 551,134 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250262,"accession_number":"0001493152-24-009575","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Tharimmune amends bylaws to lower stockholder quorum from majority to one-third","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved amendment on March 7, 2024, amending Article II, Section 2.6 of bylaws.","New quorum requirement is one-third of outstanding voting stock, down from a majority.","Amendment applies to all future stockholder meetings; no other bylaw changes reported.","Effective immediately upon board approval; no stockholder vote was required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250261,"accession_number":"0001493152-24-005462","cik":1861657,"company_name":"Canton Strategic Holdings, Inc.","ticker":"CNTN","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Tharimmune reports 11.74M shares outstanding as of Feb 8, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Share count of 11,739,676 common shares issued and outstanding as of February 8, 2024.","No changes to management, guidance, or capital structure disclosed.","No financial results, dividends, or other events reported."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":225120758.56811148,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-02-08T23:59:59+00:00|250261"}